GlassScriptPhysician profile
Stanton F Dodson
NPI 1942238803
$6,980.61
in general payments reported to CMS, 2019-2025
8 companies · $31.27 in 2025
The $31.27 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $125 · 2021: $1,732 · 2022: $4,918 · 2024: $16.75 · 2025: $31.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,115.60 | 2019-2022 | |
| Baxter Healthcare | $1,701.19 | 2020-2021 | |
| Boston Scientific Corporation | $57.41 | 2021-2022 | |
| Ethicon US, LLC | $41.50 | 2019 | |
| Janssen Biotech, INC. | $17.36 | 2025 | Erleada |
| Abbvie INC. | $16.89 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.75 | 2024 | Ultomiris |
| Jazz Pharmaceuticals INC. | $13.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanton Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.